Compounds > isoproterenol

isoproterenol and lovastatin

isoproterenol has been researched along with lovastatin in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19901 (10.00)18.7374
1990's0 (0.00)18.2507
2000's6 (60.00)29.6817
2010's3 (30.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H1
Lombardo, F; Obach, RS; Waters, NJ1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Barnett, JV; Galper, JB; Haigh, LS; Marsh, JD1
Batlle, D; Lecuona, E; Pesce, L; Ridge, K; Sznajder, JI1
Chen, MF; Lee, TJ; Long, C; Si, ML; Yang, DI1
Hohl, RJ; Martins, JB; Murry, DJ; Schmidt, MS; Xing, D1

Reviews

1 review(s) available for isoproterenol and lovastatin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

9 other study(ies) available for isoproterenol and lovastatin

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Identifying off-target effects and hidden phenotypes of drugs in human cells.
    Nature chemical biology, 2006, Volume: 2, Issue:6

    Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship

2006
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Effects of low density lipoproteins and mevinolin on sympathetic responsiveness in cultured chick atrial cells. Regulation of beta-adrenergic receptors and alpha s.
    The Journal of biological chemistry, 1989, Jun-25, Volume: 264, Issue:18

    Topics: 1-Methyl-3-isobutylxanthine; Adenosine Diphosphate Ribose; Adenylyl Cyclases; Animals; Atrial Function; Cell Division; Cells, Cultured; Chick Embryo; Cholera Toxin; Heart; Heart Atria; Heart Rate; Isoproterenol; Lipoproteins, LDL; Lovastatin; Myocardial Contraction; Myocardium; Receptors, Adrenergic, beta

1989
The GTP-binding protein RhoA mediates Na,K-ATPase exocytosis in alveolar epithelial cells.
    Molecular biology of the cell, 2003, Volume: 14, Issue:9

    Topics: Adrenergic beta-Agonists; Cell Membrane; Cloning, Molecular; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Epithelial Cells; Exocytosis; Fluorescent Antibody Technique; Humans; Intracellular Signaling Peptides and Proteins; Isoproterenol; Lovastatin; Models, Molecular; Protein Prenylation; Protein Serine-Threonine Kinases; Receptors, Adrenergic, beta; rho-Associated Kinases; rhoA GTP-Binding Protein; Sodium-Potassium-Exchanging ATPase; Tumor Cells, Cultured

2003
Statins prevent beta-amyloid inhibition of sympathetic alpha7-nAChR-mediated nitrergic neurogenic dilation in porcine basilar arteries.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2005, Volume: 25, Issue:12

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Amyloid beta-Peptides; Animals; Basilar Artery; Calcium; Cells, Cultured; Choline; Drug Interactions; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Isoproterenol; Lovastatin; Male; Nicotine; Nicotinic Agonists; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Nootropic Agents; Peptide Fragments; Receptors, Nicotinic; Superior Cervical Ganglion; Swine; Sympathetic Nervous System; Sympathomimetics; Vasodilation

2005
Lovastatin specifically prevents focal ischemic ventricular tachycardia due to triggered activity.
    Heart rhythm, 2007, Volume: 4, Issue:5

    Topics: Action Potentials; Adrenergic beta-Agonists; Analysis of Variance; Animals; Anti-Arrhythmia Agents; Antioxidants; Blood Pressure; Body Surface Potential Mapping; Cardiac Pacing, Artificial; Cyclic N-Oxides; Disease Models, Animal; Dogs; Electrophysiologic Techniques, Cardiac; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Isoproterenol; Lovastatin; Male; Mevalonic Acid; Microelectrodes; Myocardial Ischemia; Refractory Period, Electrophysiological; Research Design; Ventricular Fibrillation

2007